Psychiatric Drugs Information
Psychiatric drugs create harmful medication effects on the brain, mind and behavior. Peter R. Breggin MD has been documenting and identifying these effects for decades. Dr. Breggin's most recent medical book: Brain-Disabling Treatments in Psychiatry (2008) is the most up-to-date and thorough presentation of his overall views on the dangers associated with psychiatric medication. It describes how the supposed therapeutic effects of psychiatric drugs are in fact the result of drug-induced mental disabilities. The following very abbreviated summary should not substitute for the more thorough explanations in Brain Disabling Treatments in Psychiatry (2008):
• Antidepressants cause emotional anesthesia and numbing or sometimes euphoria, providing a fleeting, artificial relief from emotional suffering.
• Neuroleptic or antipsychotic drugs disrupt frontal lobe function, causing a chemical lobotomy with apathy and indifference, making emotionally distressed people more submissive and less able to feel.
• Mood stabilizers slow down overall brain function, dampening emotions and personal vitality.
• Benzodiazepines suppress overall brain function, sedating the individual, with temporary relief of tension or anxiety at the cost of reduced mental function.
• Stimulants blunt spontaneity and enforce obsessive behaviors in children, making them less energetic, less social, less creative and more obedient.
The individual taking the drugs or the doctor, family and classroom teacher can mistakenly interpret these effects as an improvement when they reflect dysfunction of the brain and mind. As an egregious example, millions of school children are prescribed these drugs because schools find them easer to deal with when their spontaneity is impaired and when they become more compulsively obedient.
In the long run, all psychiatric drugs tend to disrupt the normal processes of feeling and thinking, rendering the individual less able to deal effectively with personal problems and with life’s challenges. They worsen the individual’s overall mental condition and produce potentially irreversible harm to the brain.
"Psychiatric drug-induced Chronic Brain Impairment (CBI): Implications for longterm treatment with psychiatric medication," by Peter R. Breggin, MD, Intl. Journal of Risk & Safety in Medicine 2011
The syndrome of Chronic Brain Impairment (CBI)
The clinical effect of chronic exposure to psychoactive substances, including psychiatric drugs, produces effects very similar to those of close-head injury due to traumatic brain injury (TBI)  or the Postconcussive Syndrome . Generalized or global harm to the brain from any cause produces very similar mental effects. The brain and its associated mental processes respond in a very similar fashion to injuries from causes as diverse as electroshock treatment, closed head injury from repeated sports-induced concussions or TBI in wartime, chronic abuse of alcohol and street drugs, long-term exposure to psychiatric polydrug treatment, and long-term exposure to particular classes of psychiatric
drugs including stimulants, benzodiazepines, lithium and antipsychotic drugs.
Global or generalized brain impairments - those that involve the whole brain - look so much alike in their mental symptoms because the injured brain has only a limited repertoire of reactions. The healthy brain seems almost infinite in its capacity to create, so that the mental life of individuals with normal brains is very complex, rich and varied, and always unique. The wounded brain, and its associated mental malfunctions, is much more limited and pedestrian. Its remaining richness and complexity depend on the existence of sufficient remaining brain function to allow for unique self-expression.
Based on these observations I have proposed the syndrome and diagnosis of Chronic Brain Impairment (CBI). The specific cause of the CBI is added as a prefix, as in Alprazolam CBI, Antipsychotic Drug CBI, or Poly Psychiatric Drug CBI. Other examples are ECT CBI, Polydrug Abuse CBI, and Concussive CBI. Read more here.
Psychiatric Drug Use Spreads--Pharmacy Data Show a Big Rise in Antipsychotic and Adult ADHD Treatments"
Wall Street Journal, November 16, 2011
The medicating of Americans for mental illnesses continued to grow over the past decade, with one in five adults now taking at least one psychiatric drug such as antidepressants, antipsychotics and anti-anxiety medications, according to an analysis of pharmacy-claims data.
Among the most striking findings was a big increase in the use of powerful antipsychotic drugs across all ages, as well as growth in adult use of drugs for attention-deficit hyperactivity disorder—a condition typically diagnosed in childhood. Use of ADHD drugs such as Concerta and Vyvanse tripled among those aged 20 to 44 between 2001 and 2010, and it doubled over that time among women in the 45-to-65 group, according to the report.
Overall use of psychiatric medications among adults grew 22% from 2001 to 2010. The new figures, released Wednesday, are based on prescription-drug pharmacy claims of two million U.S. insured adults and children reported by Medco Health Solutions Inc., a pharmacy-benefit manager.
Read more here. And see the next article: "America's State of Mind Report" below which the Wall Street Journal based its report upon.
America’s State of Mind Report: a Medco Health Solutions, Inc. Analysis November 2011
America’s State of Mind Report is a Medco Health Solutions, Inc. analysis examining trends in the
utilization of mental health‐related medications among the insured population. The research
reviewed prescription drug claims of over two million Americans to assess the use of
antidepressants, antipsychotics, attention deficit hyperactivity disorder drugs and anti‐anxiety
treatments between 2001 and 2010.
The Report provides revealing insights into the utilization of mental health treatments along
gender lines, age groups and geography, as well as changes that have occurred over the decade.
Overview of Mental Health Medication Trends
Overall, the number of Americans on medications used to treat psychological and behavioral
disorders has substantially increased since 2001; more than one‐in‐five adults was on at least one
of these medications in 2010, up 22 percent from ten years earlier. Women are far more likely to
take a drug to treat a mental health condition than men, with more than a quarter of the adult
female population on these drugs in 2010 as compared to 15 percent of men.
Women ages 45 and older showed the highest use of these drugs overall. Yet surprisingly, it was
younger men (ages 20 to 44) who experienced the greatest increase in their numbers, rising 43
percent from 2001 to 2010.
The trends among children are opposite those of adults: boys are the higher utilizers of these
medications overall but girls’ use has been increasing at a faster rate. Read more here.